BAGNEAUX, France -- People who suffer from peanut allergies may soon find some relief.
A small pharmaceutical company in France is working on a drug that would help people tolerate peanuts.
The drug is called "Viaskin Peanut," and is administered in the form of a patch, similar to nicotine patches.
The FDA recently gave it approval for fast-track testing. If all goes well, it could be available in the U.S. by early 2018.
Peanuts are among eight food groups that account for 90 percent of serious allergic reactions in children in the U.S., according to the CDC. Others are: milk, eggs, fish, crustacean shellfish, wheat, soy and tree nuts.